[go: up one dir, main page]

HUP0202634A3 - Anticonvulsant derivatives useful in treating essential tremor - Google Patents

Anticonvulsant derivatives useful in treating essential tremor

Info

Publication number
HUP0202634A3
HUP0202634A3 HU0202634A HUP0202634A HUP0202634A3 HU P0202634 A3 HUP0202634 A3 HU P0202634A3 HU 0202634 A HU0202634 A HU 0202634A HU P0202634 A HUP0202634 A HU P0202634A HU P0202634 A3 HUP0202634 A3 HU P0202634A3
Authority
HU
Hungary
Prior art keywords
derivatives useful
essential tremor
treating essential
anticonvulsant derivatives
anticonvulsant
Prior art date
Application number
HU0202634A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HUP0202634A2 publication Critical patent/HUP0202634A2/hu
Publication of HUP0202634A3 publication Critical patent/HUP0202634A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
HU0202634A 1999-02-17 2000-02-15 Anticonvulsant derivatives useful in treating essential tremor HUP0202634A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12041399P 1999-02-17 1999-02-17

Publications (2)

Publication Number Publication Date
HUP0202634A2 HUP0202634A2 (hu) 2002-11-28
HUP0202634A3 true HUP0202634A3 (en) 2005-02-28

Family

ID=22390119

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202634A HUP0202634A3 (en) 1999-02-17 2000-02-15 Anticonvulsant derivatives useful in treating essential tremor

Country Status (24)

Country Link
US (1) US6214867B1 (hu)
EP (1) EP1158950B1 (hu)
JP (1) JP2002539088A (hu)
KR (1) KR100664612B1 (hu)
CN (1) CN1433306A (hu)
AR (1) AR035986A1 (hu)
AT (1) ATE316374T1 (hu)
AU (1) AU779823B2 (hu)
BR (1) BR0008791A (hu)
CA (1) CA2362336C (hu)
CZ (1) CZ295096B6 (hu)
DE (1) DE60025705T2 (hu)
DK (1) DK1158950T3 (hu)
ES (1) ES2257288T3 (hu)
HU (1) HUP0202634A3 (hu)
IL (2) IL144943A0 (hu)
MX (1) MXPA01008387A (hu)
MY (1) MY129238A (hu)
NO (1) NO20014026L (hu)
NZ (1) NZ513724A (hu)
TR (1) TR200103126T2 (hu)
TW (1) TWI228413B (hu)
WO (1) WO2000048549A2 (hu)
ZA (1) ZA200107564B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043731A2 (en) * 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
MXPA04002709A (es) * 2001-09-24 2005-06-06 Johnson & Johnson Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4981867A (en) 1989-12-08 1991-01-01 The Board Of Trustees Of The Leland Stanford Junior University Treatment of tremor using compounds that depress calcium currents in thalamic and other central nervous system neurons
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5735693A (en) * 1996-03-29 1998-04-07 Multi Lingua Ltd.. Method and device for learning a foreign language
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування

Also Published As

Publication number Publication date
KR20010112272A (ko) 2001-12-20
AU3364800A (en) 2000-09-04
DK1158950T3 (da) 2006-04-24
NO20014026D0 (no) 2001-08-17
MXPA01008387A (es) 2003-06-06
CA2362336A1 (en) 2000-08-24
ES2257288T3 (es) 2006-08-01
NZ513724A (en) 2004-01-30
CN1433306A (zh) 2003-07-30
CA2362336C (en) 2005-04-12
DE60025705T2 (de) 2006-08-24
AR035986A1 (es) 2004-08-04
WO2000048549A2 (en) 2000-08-24
KR100664612B1 (ko) 2007-01-04
ZA200107564B (en) 2002-12-13
IL144943A (en) 2006-08-20
JP2002539088A (ja) 2002-11-19
DE60025705D1 (de) 2006-04-13
TWI228413B (en) 2005-03-01
AU779823B2 (en) 2005-02-10
WO2000048549A3 (en) 2002-04-04
EP1158950A1 (en) 2001-12-05
BR0008791A (pt) 2005-04-05
CZ295096B6 (cs) 2005-05-18
MY129238A (en) 2007-03-30
NO20014026L (no) 2001-10-17
CZ20013011A3 (cs) 2002-06-12
US6214867B1 (en) 2001-04-10
EP1158950B1 (en) 2006-01-25
IL144943A0 (en) 2002-06-30
ATE316374T1 (de) 2006-02-15
TR200103126T2 (tr) 2002-07-22
HUP0202634A2 (hu) 2002-11-28

Similar Documents

Publication Publication Date Title
GB9912411D0 (en) Compounds useful in therapy
GB9912413D0 (en) Compounds useful in therapy
EP1145700A4 (en) Massage device
EP1062934A4 (en) MASSAGER
EP1146790A4 (en) COMPOUNDS AND METHODS
EP1223932A4 (en) COMPOUNDS AND METHODS
AU3582600A (en) Anticonvulsant derivatives useful in treating transformed migraine
GB9912410D0 (en) Compounds useful in therapy
GB9905512D0 (en) Process
GB9912416D0 (en) Compounds useful in therapy
GB9725953D0 (en) Compounds useful in therapy
GB9908814D0 (en) Process
IL144943A0 (en) Anticonvulsant derivatives useful in treating essential tremor
TW457944U (en) Massaging machine
MXPA01011014A (es) Derivados anticonvulsivos utiles en el tratamiento de dependencia de cocaina.
GB9722287D0 (en) Compounds useful in therapy
GB9905418D0 (en) Process
GB9903087D0 (en) Process
GB0206401D0 (en) Side effects treatment
GB9910769D0 (en) Compounds useful in therapy
GB9910764D0 (en) Compounds useful in therapy
GB9904691D0 (en) Compounds useful in therapy
GB9921314D0 (en) Compounds useful in therapy
GB9912425D0 (en) Compounds useful in therapy
GB9910767D0 (en) Compounds useful in therapy